ACC/AHA Heart‑Failure Staging and NYHA Functional Classification

ACC/AHA Staging System

The American College of Cardiology/American Heart Association (ACC/AHA) staging system categorizes heart‑failure progression from Stage A (at‑risk) to Stage D (advanced) and is progressive and irreversible; patients move forward through stages but cannot revert to earlier stages even with optimal therapy. [1][3]
Stage A identifies individuals with risk factors (e.g., hypertension, coronary artery disease, diabetes) without structural heart disease or symptoms; management focuses on modifying risk factors to prevent disease evolution. [1][4]
Stage B comprises asymptomatic patients who have structural heart disease (e.g., left‑ventricular hypertrophy or impaired systolic function) but no heart‑failure symptoms; ACE inhibitors and β‑blockers are recommended to avert symptomatic heart failure. [1][4]
Stage C includes patients with current or prior heart‑failure symptoms together with underlying structural heart disease; this stage represents the majority of heart‑failure cases and requires comprehensive guideline‑directed medical therapy, including diuretics for fluid overload. [1][4]
Stage D denotes refractory heart failure despite maximal medical therapy; patients are candidates for advanced interventions such as mechanical circulatory support, continuous inotropic infusion, cardiac transplantation, or hospice care. [1][3]

The New York Heart Association (NYHA) classification evaluates symptom severity and can fluctuate over time with treatment or disease progression; it is a subjective assessment made by the healthcare provider. [1][2]
Class I: No limitation of ordinary physical activity; typical activities do not provoke fatigue, palpitations, or dyspnea. 5
Class II: Slight limitation of physical activity; patients are comfortable at rest but experience fatigue, palpitations, or dyspnea with ordinary activity. 5
Class III: Marked limitation of physical activity; patients are comfortable at rest, yet less‑than‑ordinary activity induces fatigue, palpitations, or dyspnea. 5
Class IV: Inability to carry out any physical activity without discomfort; heart‑failure symptoms are present at rest or with minimal exertion. 5

The ACC/AHA staging system complements the NYHA functional classification; stages identify disease presence and progression, whereas NYHA class reflects current symptom burden. [1][2]
Stages A and B are not overt heart failure; they serve to flag patients who may benefit from early, preventive interventions. [1][3]
Stage assignment is unidirectional: a patient who reaches Stage C remains in Stage C even if NYHA class improves to Class I with therapy. [1][2]
NYHA class can change frequently in response to treatment, while the underlying stage remains fixed, supporting the use of both systems for longitudinal management. [2][8]
Therapeutic decisions are anchored to stage: each ACC/AHA stage has specific recommended pharmacologic or device therapies that remain appropriate regardless of NYHA class fluctuations. [1][2]